Bevacizumab Injectable

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179
Version
20230425
PublisherAmerican Society of Clinical Oncology StewardDate2023-04-25T01:01:01-04:00Purpose

(Clinical Focus: The purpose of this value set is to represent concepts of medication bevacizumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication bevacizumab, bevacizumab biosimilars; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Expansion
<<>>>
CodeDisplaySystem
2599043http://www.nlm.nih.gov/research/umls/rxnorm
2627650http://www.nlm.nih.gov/research/umls/rxnorm
1657066http://www.nlm.nih.gov/research/umls/rxnorm
1657073http://www.nlm.nih.gov/research/umls/rxnorm
2627658http://www.nlm.nih.gov/research/umls/rxnorm
2599051http://www.nlm.nih.gov/research/umls/rxnorm
2268047http://www.nlm.nih.gov/research/umls/rxnorm
2046140http://www.nlm.nih.gov/research/umls/rxnorm
2268039http://www.nlm.nih.gov/research/umls/rxnorm
2046148http://www.nlm.nih.gov/research/umls/rxnorm